In a pneumonia model of intratracheal Pseudomonas aeruginosa intraperitoneal administration of anti-MCP1/CCL2 aggravated lung tissue injury and did not decrease infiltrated cells in the alveolar space 48 h after infection66. Here, CCL2 is linked to pneumonia.